Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrenner, Menachem-
dc.contributor.authorSundaram, Rangarajan K-
dc.contributor.authorYermack, David-
dc.date.accessioned2008-05-29T08:06:56Z-
dc.date.available2008-05-29T08:06:56Z-
dc.date.issued1998-02-08-
dc.identifier.urihttp://hdl.handle.net/2451/26855-
dc.description.abstractThis paper examines the practice of resetting of the terms of previously-issued executive stock options. We identify the properties of the typical reset option, characterize the firms that have reset options, and develop a model to value options that may be reset. In our sample of 396 executives whose options had terms reset in 1992-95 period, a large majority had exercise prices reset to the market price. This resulted in a reduction of the typical option's exercise price by about 40%. Slightly less than half of these options also had their maturities extended, generally receiving a new expiration of 10 years. We find that resetting has a strong negative relationship with firm performance even after correcting for industry performance. Resetting is also significantly more common among small firms than among large firms. However, few other industry- or firm-specific factors appear to matter. Finally, we find that the possibility of resetting does not have a large impact on the ex-ante value of an option award, but the ex-post gain can be substantial.en
dc.language.isoen_USen
dc.relation.ispartofseriesFIN-98-010en
dc.titleAltering the Terms of Executive Stock Optionsen
dc.typeWorking Paperen
Appears in Collections:Economics Working Papers

Files in This Item:
File Description SizeFormat 
wpa98010.pdf1.84 MBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.